NEW YORK (GenomeWeb) – Quidel today reported preliminary revenues for the fourth quarter of 2015 well below analyst forecasts.

Due to a weak influenza season, the firm now expects Q4 revenues between $52 million and $53 million, below analysts' consensus estimate of $64 million.

Investors reacted negatively to the news, sending Quidel's shares down around 7 percent to $17.67 in mid-morning trade on the Nasdaq. The shares had fallen to as low as $16.71 earlier in the session.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Popular Mechanics reports that Caltech researchers have built a prototype nanobot using DNA.

The Sacramento Bee writes that direct-to-consumer genetic testing connected a woman to sperm donor-conceived half siblings.

In PLOS this week: gene expression catalog for sheep, viral diversity among respiratory samples from camels, and more.